Cargando…
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) infection is associated with high mortality and has no approved antiviral therapy. We aimed to compare ribavirin and interferon alfa-2a treatment for patients with severe MERS-CoV infection with a supportive therapy only. METHODS: I...
Autores principales: | Omrani, Ali S, Saad, Mustafa M, Baig, Kamran, Bahloul, Abdelkarim, Abdul-Matin, Mohammed, Alaidaroos, Amal Y, Almakhlafi, Ghaleb A, Albarrak, Mohammed M, Memish, Ziad A, Albarrak, Ali M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106357/ https://www.ncbi.nlm.nih.gov/pubmed/25278221 http://dx.doi.org/10.1016/S1473-3099(14)70920-X |
Ejemplares similares
-
Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia
por: Saad, Mustafa, et al.
Publicado: (2014) -
A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case
por: Omrani, Ali S., et al.
Publicado: (2013) -
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2014) -
Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients
por: Almekhlafi, Ghaleb A., et al.
Publicado: (2016) -
GeneXpert MTB/RIF Testing in the Management of Patients with Active Tuberculosis; A Real Life Experience from Saudi Arabia
por: Omrani, Ali S., et al.
Publicado: (2014)